Stem Cell Therapeutic and Research Reauthorization Act of 2025

Jul 20, 2026

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)

Jul 20, 2026

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

Jul 20, 2026

DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.

Jul 20, 2026

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

Jul 20, 2026

Considered under suspension of the rules. (consideration: CR H4642-4632)

Jul 20, 2026

Motion to reconsider laid on the table Agreed to without objection.

Jul 2, 2026

Placed on the Union Calendar, Calendar No. 629.

Jul 2, 2026

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

Jul 2, 2026

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

May 21, 2026

Committee Consideration and Mark-up Session Held

May 21, 2026

Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

May 13, 2026

Forwarded by Subcommittee to Full Committee by Voice Vote.

May 13, 2026

Subcommittee Consideration and Mark-up Session Held

Sep 4, 2025

Referred to the Subcommittee on Health.

Sep 4, 2025

Introduced in House

Sep 4, 2025

Introduced in House

Sep 4, 2025

Referred to the House Committee on Energy and Commerce.

HR 5160Stem Cell Therapeutic and Research Reauthorization Act of 2025